Laumas Sandeep 4/A
4/A · Unicycive Therapeutics, Inc. · Filed Jun 15, 2026
Research Summary
AI-generated summary of this filing
Unicycive (UNCY) Director Laumas Sandeep Receives RSU Award
What Happened
Laumas Sandeep, a director of Unicycive Therapeutics, received two restricted stock unit (RSU) awards on 2026-05-14 totaling 126,300 RSUs (84,200 + 42,100). The grants are reported as derivative acquisitions at $0.00 per share (aggregate reported value $0), meaning these are stock awards subject to vesting rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-05-14; Form 4 filed as an AMENDED report on 2026-06-15 (appears to be filed after the transaction date).
- Reported acquisition: 84,200 RSUs (footnote F1) and 42,100 RSUs (footnote F2) at $0.00 per share.
- Vesting (per footnotes):
- F1 (84,200 RSUs): 11,694 shares vested upon grant; remaining 2,339 RSUs vest monthly over 31 months beginning June 1, 2026.
- F2 (42,100 RSUs): 17,542 shares vested upon grant; remaining 3,508 RSUs vest monthly over 7 months beginning June 1, 2026.
- Shares owned after transaction: not disclosed in this filing.
- Filing status: AMENDED Form 4 filed 2026-06-15 for transactions dated 2026-05-14 (note the filing date is after the transaction date).
Context
RSU grants are awards that convert to common shares according to the stated vesting schedule; they do not represent an immediate cash purchase or sale by the insider. Such grants are common as compensation or retention tools and do not, by themselves, indicate buying or selling intent.
Insider Transaction Report
- Award
Restricted Stock Units
[F1]2026-05-14+84,200→ 84,200 totalExercise: $0.00→ Common Stock (84,200 underlying) - Award
Restricted Stock Units
[F2]2026-05-14+42,100→ 126,300 totalExercise: $0.00→ Common Stock (42,100 underlying)
Footnotes (2)
- [F1]Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. 11,694 shares vest upon grant and 2,339 vest monthly over 31 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer.
- [F2]Represents grant of restricted stock units (the "Annual RSU Award") payable solely in common stock of the Issuer. 17,542 shares vest upon grant and 3,508 vest monthly over 7 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer.